VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 149 filers reported holding VENTYX BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,926 | +930.7% | 228,220 | +872.9% | 0.01% | – |
| Q2 2023 | $769 | +31.2% | 23,458 | +34.0% | 0.00% | – |
| Q1 2023 | $586 | +65.1% | 17,504 | +61.6% | 0.00% | – |
| Q4 2022 | $355 | -99.7% | 10,835 | +255.5% | 0.00% | – |
| Q3 2022 | $106,000 | -96.9% | 3,048 | -98.9% | 0.00% | -100.0% |
| Q2 2022 | $3,406,000 | -13.2% | 278,383 | -3.7% | 0.00% | -33.3% |
| Q1 2022 | $3,923,000 | – | 289,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |